World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
106
Citations
49328
World Ranking
6437
National Ranking
68

Masafumi Kitakaze publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Masafumi Kitakaze sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 944 publications — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Masafumi Kitakaze D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Masafumi Kitakaze sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 106 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Masafumi Kitakaze is affiliated with Southern Medical University in China and has an extensive research portfolio primarily in medicine, with a strong focus on cardiology and cardiovascular medicine. Their work spans multiple intersecting subfields including endocrinology, diabetes and metabolism, molecular biology, surgery, and pulmonary and respiratory medicine.

The main research topics addressed by Kitakaze encompass cardiovascular function and risk factors, heart failure treatment and management, and diabetes treatment and management. Additional topics include pancreatic function and diabetes, cardiovascular effects of exercise, metabolism related to diabetes and cancer, and diabetes management and research.

Kitakaze's publication record includes a selection of recent papers notable for their focus on heart failure and related therapies. These include:

  • Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction, 2022, New England Journal of Medicine
  • Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes, 2020, JAMA
  • Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction, 2020, Circulation
  • Baseline Characteristics of Patients With HF With Mildly Reduced and Preserved Ejection Fraction, 2022, JACC Heart Failure
  • Efficacy and Safety of Dapagliflozin According to Frailty in Heart Failure With Reduced Ejection Fraction, 2022, Annals of Internal Medicine

Frequent coauthors in Kitakaze's work include Shin Ito, Scott D. Solomon, John J.V. McMurray, Felipe A. Martínez, and Pardeep S. Jhund. This indicates a collaborative network with other researchers specializing in cardiovascular medicine and related clinical trials.

The scientist's frequent publication venues reflect a focus on cardiovascular and clinical research. Notable journals where Kitakaze has published multiple papers include Cardiovascular Drugs and Therapy, Circulation, JACC Asia, Scientific Reports, and European Heart Journal.

Best Publications

  • Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

    John J.V. McMurray;Scott D. Solomon;Silvio E. Inzucchi;Lars Køber

  • Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy

    Masanori Asakura;Masafumi Kitakaze;Seiji Takashima;Yulin Liao

  • Identification of RNF213 as a Susceptibility Gene for Moyamoya Disease and Its Possible Role in Vascular Development

    Wanyang Liu;Daisuke Morito;Seiji Takashima;Yohei Mineharu

  • Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure.

    Noritoshi Nagaya;Junji Moriya;Yoshio Yasumura;Masaaki Uematsu

  • Prolonged Endoplasmic Reticulum Stress in Hypertrophic and Failing Heart After Aortic Constriction Possible Contribution of Endoplasmic Reticulum Stress to Cardiac Myocyte Apoptosis

    Ken-ichiro Okada;Tetsuo Minamino;Yoshitane Tsukamoto;Yulin Liao

  • Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy

    Masao Takemoto;Koichi Node;Hironori Nakagami;Yulin Liao

  • ER stress in cardiovascular disease.

    Tetsuo Minamino;Masafumi Kitakaze

  • Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy.

    Koichi Node;Masashi Fujita;Masafumi Kitakaze;Masatsugu Hori

  • Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials

    Masafumi Kitakaze;Masanori Asakura;Jiyoong Kim;Yasunori Shintani

  • Endoplasmic Reticulum Stress As a Therapeutic Target in Cardiovascular Disease

    Tetsuo Minamino;Issei Komuro;Masafumi Kitakaze

  • JCS 2017/JHFS 2017 Guideline on Diagnosis and Treatment of Acute and Chronic Heart Failure ― Digest Version ―

    Hiroyuki Tsutsui;Mitsuaki Isobe;Hiroshi Ito;Ken Okumura

  • Increased Endoplasmic Reticulum Stress in Atherosclerotic Plaques Associated With Acute Coronary Syndrome

    Masafumi Myoishi;Hiroyuki Hao;Tetsuo Minamino;Kouki Watanabe

  • Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis

    Seiji Takashima;Masafumi Kitakaze;Masanori Asakura;Hiroshi Asanuma

  • Pathophysiology of myocardial reperfusion injury: preconditioning, postconditioning, and translational aspects of protective measures

    Shoji Sanada;Issei Komuro;Masafumi Kitakaze

  • Effect of dapagliflozin on worsening heart failure and cardiovascular death in patients with heart failure with and without diabetes

    Mark C Petrie;Subodh Verma;Kieran F Docherty;Silvio E Inzucchi

  • Evidence for Preconditioning by Isoflurane in Coronary Artery Bypass Graft Surgery

    Denis Belhomme;Jacqueline Peynet;Moez Louzy;Jean-Marie Launay

  • Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function

    Ryo Iwamoto;Satoru Yamazaki;Masanori Asakura;Seiji Takashima

  • A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF).

    John J V McMurray;David L DeMets;Silvio E Inzucchi;Lars Køber

  • Plaque gruel of atheromatous coronary lesion may contribute to the no-reflow phenomenon in patients with acute coronary syndrome

    Jun-ichi Kotani;Shinsuke Nanto;Gary S. Mintz;Masafumi Kitakaze

  • Failure to prevent progressive dilation of ascending aorta by aortic valve replacement in patients with bicuspid aortic valve: comparison with tricuspid aortic valve.

    Hisayo Yasuda;Satoshi Nakatani;Marie Stugaard;Yuko Tsujita-Kuroda

Frequent Co-Authors

Masatsugu Hori
Masatsugu Hori Osaka University
Hitonobu Tomoike
Hitonobu Tomoike National Cardiovascular Research Center
Masakazu Yamagishi
Masakazu Yamagishi Osaka University of Human Sciences
Takenobu Kamada
Takenobu Kamada Osaka University
Shiro Kamakura
Shiro Kamakura National Cardiovascular Research Center
Soichiro Kitamura
Soichiro Kitamura National Archives and Records Administration
Issei Komuro
Issei Komuro University of Tokyo
Naoki Mochizuki
Naoki Mochizuki National Cerebral and Cardiovascular Center
Shogo Ozawa
Shogo Ozawa Iwate Medical University
Jun-ichi Sawada
Jun-ichi Sawada University of Shizuoka

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring a future in Medicine but want flexible or alternative pathways, there are several online degree options to consider. Many students begin their healthcare careers through online ADN programs (Associate Degree in Nursing), which provide a convenient route to becoming a registered nurse. These programs often offer streamlined coursework and clinical experiences that fit busy schedules.

For those interested in administrative or technical roles, online medical billing and coding schools that accept fafsa make it easier to fund your education while gaining valuable skills in an in-demand field. Similarly, aspiring practical nurses can find opportunities through lpn program no entrance exam options, helping you bypass traditional barriers to entry and start your career sooner.

If your interests lie in the leadership or managerial side of health services, accredited healthcare administration degrees can fast-track your progress into supervisory positions or healthcare management. These accessible online pathways open doors across the healthcare industry for students from all backgrounds.

Best Scientists Citing Masafumi Kitakaze

Trending Scientists